Ovata Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Ovata Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-600	Closed	-$3K	–	103
2022 Q1	$3K	Buy	+600	New	+$2.46K	﹤0.01%	168

Other funds holding NAUT

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

Ovata Capital Management's NAUT Position: Q2 2022 in Review

Ovata Capital Management sold out of Nautilus Biotechnolgy (NAUT) in Q2 2022, closing a stake of 600 shares — an estimated $3K sold.

Ovata Capital Management first reported a position in NAUT in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 83 funds tracked by Wall St. Rank hold NAUT as of Q2 2022.

Ovata Capital Management reported no remaining Nautilus Biotechnolgy position as of Q2 2022 after selling out during the quarter.
Ovata Capital Management sold 600 Nautilus Biotechnolgy shares in Q2 2022, an estimated $3K.
Ovata Capital Management first reported a position in Nautilus Biotechnolgy in Q1 2022 and held it in 1 quarter.
Ovata Capital Management's Nautilus Biotechnolgy position peaked at $3K in Q1 2022.
83 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2022.

Based on Ovata Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.